Effect of Antenatal Corticosteroids in Late Preterm

NCT01710384 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2012-10-19

No results posted yet for this study

Summary

To test the effect on premature infants of a one-time course of betamethasone administered in weeks 34-36 of gestation.

Conditions

  • Late Preterm

Interventions

DRUG

betamethasone

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-11-30
Completion
2015-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01710384 on ClinicalTrials.gov